Group dynamic
Collaboration is the key to scientific success. Without a sound group set-up, most research, production and distribution projects would be impossible to lift. The complexity of today’s pharmaceutical industry requires teams not only to perform at their very best, but to remain open to change so that they can adapt quickly when necessary. Agility is the name of the game.
Published on 13/12/2022
Photos by Laurids Jensen and Andy Kwok
Chemical Biology research group leaders Jeremy Jenkins (US) and John Tallarico (global).
Ulrich Schopfer, leader of the Chemical Biology research group in Basel.
The PharmaLedger Team (from left to right): Amit D. Deshpande, Darlene MacDonald, Daniel Fritz, Patrick Maher, Marco Cuomo, Gwenaelle Nicolas, Francesco Spoto, Sonja Steiner, Jan Jeker.
The Cryo-EM team (from left to right): Andreas Schenk, Christian Wiesmann, Lukas Kater, Celine Be, Simone Cavadini, Maryam Khoshouei, Honnappa Srinivas.
The Helios team (from left to right): Jonathan Solomon, Christopher Straub, Eva d’Hennezel, Artiom Cernijenko, Anna Magracheva, Aleem Fazal, Beth Fortnam, Lei Xu, Simone Bonazzi, Michael Visser.
The Kidney Organoid group (from left to right): Fiona Routet, Vincent Unterreiner, Noelle Pierret, Daniela Gabriel, Patrick Misun, Isabelle Claerr, Rina Yamamoto, Rosemarie Ungricht, Philipp Hoppe, Solange Vidal, Saba Rezakhani, Manuel Scheidmann, Laure Guibbal.
The Radioligand team in Basel. Back (from left to right): Delphine Gorses, Markus Reschke, Joana Silva, Luisa Deberle, Emanuele Mauro, Milene Walter, Xavier Miot. Front (from left to right): Barbara Schacher Engstler, Emmanuelle Briard, Sravanth Hindupur.
Back (from left to right): Axel Baxarias, Josefine Reber, Ralph Bessey, Charlène Hartnagel, Danielle Park, Gonçalo Clemente, Alexander Kristian, Elise Simon. Front (from left to right): Stéphanie Barbé, Fanny Schaeffer, Philipp Holzer, Emeline Mandon.
